Abbott Laboratories Q3 Adj. EPS $1.42, Inline, Sales $13.013B Beat $12.998B Estimate
Benzinga Newsdesk 1 week ago
NewsEarningsHotEarnings Beats
Abbott Laboratories (NYSE:ABT) reported quarterly earnings of $1.42 per share which met the analyst consensus estimate. This is a 9.23 percent increase over earnings of $1.30 per share from the same period last year.
Abbott Laboratories (NYSE:ABT) reported quarterly earnings of $1.42 per share which met the analyst consensus estimate. This is a 9.23 percent increase over earnings of $1.30 per share from the same period last year. The company reported quarterly sales of $13.013 billion which beat the analyst consensus estimate of $12.998 billion by 0.12 percent. This is a 14.46 percent increase over sales of $11.369 billion the same period last year.